Fremanezumab
Products Fremanezumab was approved in the United States in 2018 and in the EU and Switzerland in 2019 as a solution for injection for subcutaneous use (Ajovy). Structure and properties Fremanezumab is a humanized IgG2Δa/kappa monoclonal antibody directed against CGRP (calcitonin gene-related peptide). The antibody is produced by biotechnological methods, consists of 1324 amino acids, … Fremanezumab
